tiprankstipranks
Trending News
More News >
Enzon Pharmaceuticals (ENZN)
OTHER OTC:ENZN
US Market

Enzon Pharmaceuticals (ENZN) Income Statement

Compare
91 Followers

Enzon Pharmaceuticals Income Statement

Last quarter (Q3 2025), Enzon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Enzon Pharmaceuticals's net income was $-824.00K. See Enzon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 26.00K$ 0.00$ 26.00K$ 701.00K$ 52.00K
Gross Profit
$ 26.00K$ 0.00$ 26.00K$ 701.00K$ 52.00K
Operating Expenses
$ 1.35M$ 1.04M$ 1.06M$ 1.17M$ 1.36M
Depreciation and Amortization
$ 1.33M$ 2.26M$ 1.03M$ 469.00K$ 1.30M
EBITDA
$ 0.00$ 3.48M$ 0.00$ 0.00$ 0.00
Operating Income
$ -1.33M$ -1.04M$ -1.03M$ -469.00K$ -1.30M
Other Income/Expenses
$ 2.45M$ 2.26M$ 646.00K$ 7.00K$ 1.00K
Pretax Income
$ 1.13M$ 1.22M$ -386.00K$ -462.00K$ -1.30M
Net Income
$ 778.00K$ 98.00K$ -186.00K$ -469.00K$ -1.31M
Per Share Metrics
Basic EPS
$ -0.01$ 0.00$ -0.02$ -0.03$ -0.03
Diluted EPS
$ -0.01$ 0.00$ -0.02$ -0.03$ -0.03
Weighted Average Shares Outstanding
74.22M 74.24M 74.22M 74.22M 51.10M
Weighted Average Shares Outstanding (Diluted)
74.22M 74.22M 74.22M 74.22M 51.10M
Currency in USD

Enzon Pharmaceuticals Earnings and Revenue History